In hospitals, operating rooms and doctors’ offices around Australia, advanced technology from Johnson & Johnson Medical is used to save lives and restore the joys of living. Our products are used to treat a wide range of diseases, injuries and medical conditions and can only be purchased and used by licensed healthcare practitioners, hospitals and clinics.
Our products keep people mobile, provide surgeons with specialist technology and medical devices and provide treatment options for diseases such as morbid obesity. You may know us better by one of our brands – Advanced Sterilisation Products, Bariatric Edge, Biosense Webster, Codman, Cordis, DePuy, DePuy Mitek, DePuy Spine, Ethicon, Ethicon Endo-Surgery or Women’s Health & Urology.
Advanced Sterilization Products (ASP) is a leading developer of innovative instrument sterilisation, high level disinfection, and cleaning technologies dedicated to protecting patients, healthcare workers, and the environment. Our products focus as much on safety as they do on efficacy and cost-effectiveness. Utilising advanced instrument-processing technologies, these products help customers to promote positive patient outcomes while controlling costs and increasing productivity. For more information visit www.sterrad.com
It is now understood that severe or morbid obesity is not just the result of excess eating but is also a chronic disease with many contributing factors. Our Bariatric Edge business provides treatment options for dealing with obesity through laparoscopic gastric banding, gastric bypass and other procedures. A website has been established to help provide consumers with information of the associated risks of obesity and the surgical options available to them. For more information on Bariatric Edge visit www.bariatricedge.com
Biosense Webster provides diagnostic and therapeutic products for the treatment of cardiac arrhythmias. The field, known as electrophysiology, has seen many changes in the past 10 years and Biosense Webster has been the company that has delivered many of the technological advances. Perhaps the biggest contribution Biosense Webster has made has been to invent and reinvent the 3-dimensional mapping system, which has opened up the treatment of previously untreatable arrhythmias, most notably atrial fibrillation and ventricular tachycardia. Read more about Biosense Webster at www.biosensewebster.com
Codman develops and markets a wide range of diagnostic and therapeutic products for the treatment of central nervous system disorders and the neurovascular management of aneurysms and strokes. Its focus is on intractable pain management, paediatric and adult hydrocephalus, and neuro critical care. Codman products include drug pumps, cerebrospinal fluid shunts, advanced neuro-monitoring equipment and electrosurgical systems. For more information about Codman visit www.codman.com
Cordis encompasses endovascular and cardiology devices. Cordis Endovascular is a recognised leader in providing physicians with breakthrough treatment solutions for peripheral vascular disease and obstructive diseases.
The cardiology portfolio encompasses tools required by the interventional cardiologist to treat coronary artery disease. Cordis were first to market a drug-eluting stent to address the problem of restenosis, which occurs when a treated vessel becomes blocked again, following intervention. This portfolio also includes additional cardiovascular technologies such as sheaths, catheters, balloons and wires which are required by the physician to perform cardiovascular interventional procedures. For more information on Cordis visit www.cordis.com
DePuy has led development in orthopaedic product design and manufacture throughout the world for over a century. Orthopaedic milestones laid down by DePuy include the development of the first artificial hip, the first use of bone cement, and the first mobile bearing knee.
The DePuy companies’ product portfolio addresses a range of solutions for patients and professionals including products for reconstructing damaged or diseased joints; repairing and reconstructing traumatic skeletal injuries; facilitating the treatment of spinal disorders and deformity; surgical treatment of neurological and central nervous system disorders; and devices in sports medicine for the treatment of soft tissue injuries.
DePuy Mitek is a leading developer, manufacturer and marketer of innovative medical devices, with focus on sports medicine and reconstruction. DePuy Mitek’s portfolio extends to a wide array of innovative products for anterior cruciate ligament, meniscus repair, and cartilage repair surgery in the knee. The company continues to focus on future biologic solutions to these pathologies. More information is available from the DePuy Mitek site http://www.depuy.com/Pages/DePuyMitek.aspx
DePuy Spine is a leading designer, manufacturer, and supplier of orthopaedic devices and supplies innovative solutions to a wide range of spinal conditions. DePuy Spine's products are used primarily by orthopaedic and spinal surgeons in both surgical and non-surgical therapies to treat patients with conditions resulting from degenerative diseases, deformities, trauma, and sports-related injuries. These include rod, screw and hook systems, and plates for the spine. For more information about innovative products from DePuy Spine visit www.depuyspine.com
Ethicon manufactures and sells products for wound closure and cardiovascular surgery. Ethicon is the worldwide leader in suture products and suture technology, and is one of the most recognisable and well-respected brand names in the hospital environment. It has a long history of innovation in providing products, including sutures, topical adhesives, surgical meshes and wound drains, that enhance patient care. For more information on Ethicon visit www.ethicon.com
Ethicon Endo-Surgery develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing particularly on the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynaecology and surgical oncology. Our vision is to transform patient care through innovation. The company produces procedure-enabling devices that facilitate earlier detection and treatment of disease, less invasive treatment, reduced pain and suffering, and quicker return to normal activity. More information about Ethicon Endo-Surgery can be found at www.ethiconendo.com
Women’s Health and Urology is dedicated to providing innovative, minimally invasive treatments for common urologic and women's health conditions. The division offers solutions for enlarged prostate (benign prostatic hyperplasia), female stress urinary incontinence, pelvic floor repair, post-surgical adhesions, heavy periods (menorrhagia), and benign uterine conditions, such as fibroids and polyps. For more information visit www.gynecare.com